6885 — BRIM Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for BRIM Biotechnology, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	424	838	1,696	1,849	1,158
Net Total Accounts Receivable
Net Total Receivables	0.37	0.448	6.24	10	10
Total Inventory
Prepaid Expenses
Total Current Assets	431	849	1,713	1,876	1,209
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.62	7.99	6.37	11.8	14.5
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	495	940	1,779	2,411	1,828
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.2	22.5	42	351	66.9
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	17.6	25.3	42.2	354	173
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	478	915	1,737	2,056	1,655
Total Liabilities & Shareholders' Equity	495	940	1,779	2,411	1,828
Total Common Shares Outstanding